Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.

scientific article

Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/OXFORDJOURNALS.ANNONC.A059157
P698PubMed publication ID7542021

P50authorBengt GlimeliusQ30830855
P2093author name stringL Påhlman
O Nyrén
P O Sjödén
W Graf
K Hoffman
U Haglund
P433issue3
P921main subjectcost-effectiveness analysisQ1754768
chemotherapyQ974135
P304page(s)267-274
P577publication date1995-03-01
P1433published inAnnals of OncologyQ326122
P1476titleCost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.
P478volume6

Reverse relations

cites work (P2860)
Q61868238A clinical nomogram for predicting long-term survival in advanced colorectal cancer
Q44480327A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer
Q36614969A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer
Q35768031Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes
Q36291291Assessing patients' needs and preferences in the management of advanced colorectal cancer
Q33761838Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature
Q36106736Benefit-risk assessment of irinotecan in advanced colorectal cancer
Q24236634Chemotherapy for advanced gastric cancer
Q24244040Chemotherapy for advanced gastric cancer
Q38604012Chemotherapy for advanced gastric cancer.
Q33541099Chemotherapy for advanced pancreatic cancer: it may no longer be ignored
Q77203325Chemotherapy in advanced pancreatic adenocarcinoma
Q35108798Chemotherapy in gastric cancer: a review and updated meta-analysis
Q61868286Chemotherapy of oesophago-gastric cancer
Q35039124Colorectal cancer in the elderly: is palliative chemotherapy of value?
Q93911723Colorectal cancer: treatment of advanced disease
Q35094252Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis
Q58883872Cost identification of Nordic FLIRI, Nordic FLOX, XELIRI and XELOX in first-line treatment of advanced colorectal cancer in Sweden – A clinical practice model approach
Q39015252Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer
Q34615968Cost-effectiveness analysis of colorectal cancer treatments.
Q35382059Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer
Q83204605Cost-effectiveness of gemcitabine + cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer
Q77221752Cost-effectiveness of hepatic artery infusion chemotherapy
Q46320846Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer
Q34759802Cost-effectiveness of preoperative biliary drainage for obstructive jaundice in pancreatic and periampullary cancer
Q37246292Costs and trends in pancreatic cancer treatment
Q34427755Disease management considerations: disease management considerations
Q73304002Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer
Q50666978Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer.
Q52223063Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer.
Q35629061First-line treatment strategies to improve survival in patients with advanced colorectal cancer
Q36329208Integrating palliative medicine into an oncology practice
Q36254159Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.
Q35666090Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy
Q61868280Medical management of advanced gastric cancer
Q33413448Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study
Q40860038Multidisciplinary case teams: an approach to the future management of advanced colorectal cancer
Q33875868New directions in the treatment of colorectal cancer: a look to the future
Q35111182Palliative Treatment of Patients with Colorectal Cancer
Q41739152Palliative chemotherapy
Q34021183Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group
Q57693104Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration
Q33658659Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
Q53604465Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
Q57758626Should patients with advanced colorectal cancer be treated with chemothreapy?
Q24246675Supportive care for patients with gastrointestinal cancer
Q36620872Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials
Q50996446The value of palliative gastrectomy in gastric cancer with distant metastasis.
Q33545323Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer
Q36292847Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer
Q78316496[Measure of quality of life in patients with metastatic colorectal cancer: techniques and main results]
Q73869646[Role of first-line palliative chemotherapy in metastatic colorectal cancer]
Q79861920[Surgical treatment of osseous metastases of the pelvis]
Q86578814[Treatment of gastric cancer]

Search more.